S. J. Cashman
- Nephrology top 5%
- Immunology
- Pulmonary and Respiratory Medicine
- Immunology and Allergy top 5%
- Molecular Biology
- Co-authors
- Charles D. PuseyDavid J. EvansAndrew J. ReesAlbert C. ShawNaohisa TomosugiJ. MossM C BarrettJohn J. Reynolds
- Topics
- Renal Diseases and Glomerulopathies (8 papers)Vasculitis and related conditions (5 papers)Cell Adhesion Molecules Research (5 papers)
- Partner nations
- United KingdomSwitzerlandFrance
In The Last Decade
S. J. Cashman
13 papers receiving 426 citations
Peers
Comparison fields: 5 of 60
- Nephrology 188
- Immunology 139
- Pulmonary and Respiratory Medicine 122
- Immunology and Allergy 99
- Molecular Biology 76
Countries citing papers authored by S. J. Cashman
This map shows the geographic impact of S. J. Cashman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. Cashman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. Cashman more than expected).
Fields of papers citing papers by S. J. Cashman
This network shows the impact of papers produced by S. J. Cashman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. Cashman. The network helps show where S. J. Cashman may publish in the future.
Co-authorship network of co-authors of S. J. Cashman
This figure shows the co-authorship network connecting the top 25 collaborators of S. J. Cashman. A scholar is included among the top collaborators of S. J. Cashman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. Cashman. S. J. Cashman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 41 | |
| 3 | A single-chain Fv reactive with the Goodpasture antigen. | 1 |
| 4 | Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. | 33 |
| 5 | 53 | |
| 6 | 24 | |
| 7 | 26 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 142 | |
| 11 | 43 | |
| 12 | 1 | |
| 13 | 16 | |
| 14 | 1 | |
| 15 | Experimental interstitial renal fibrosis in rats: nephritis induced by N-(3,5-dichlorophenyl)succinimide. | 44 |
About S. J. Cashman
S. J. Cashman is a scholar working on Nephrology, Immunology and Allergy and Rheumatology, having authored 15 papers that have together received 432 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (8 papers), Vasculitis and related conditions (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Nephrology (188 citations), Immunology and Allergy (99 citations) and Immunology (139 citations). S. J. Cashman has collaborated with scholars based in United Kingdom, Switzerland and France. Frequent co-authors include Charles D. Pusey, David J. Evans, Andrew J. Rees, Albert C. Shaw, Naohisa Tomosugi, David J. Evans, J. Moss, M C Barrett, John J. Reynolds and Jean‐Yves Bonnefoy. Their work appears in journals such as The Lancet, The Journal of Immunology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.